What happens at NIT?
Why is NIT called a translator?
NIT is a Translator, focused on the translation of neurotechnology innovations from the lab to patients and the marketplace. We refer to NIT as a Translator, because it is fundamentally different from other types of programs. NIT is not an incubator; not an accelerator; not a venture capital firm; not a contract manufacturing house; not a clinical trialing organization.per se.Instead, NIT brings the best of what each of these other entities has tried to deliver, comprehensively, under one translational Center, borrowing their best attributes, but transforming them into an entity that provides a cocoon for your companys success in todays challenging landscape.
In stark contrast to other models, NIT holds ready investment capital for investment in early and advanced stages of your companys development. NIT focuses on a select number of high-quality, venture-fundable, commercially-oriented companies. NIT sources projects globally, while also having access to a rich pipeline of innovation. And, NIT leverages a robust infrastructure of on-site and nearby resources from already-committed Partners. The result: a comprehensive solution, providing the expertise, resources, and capital to propel your company from concept-to-clinic, and subsequently to commercial success.
What types of companies is NIT seeking?
NIT will develop a select number of high-quality, venture-fundable, commercially-oriented companies focused on neurotechnology innovation. NIT companies will be carefully chosen, funded, and nurtured within the NIT ecosystem only if they: (1) demonstrate a sufficient level of scientific validation and mitigation (or manageability) of technical risks; (2) target a clear unmet clinical need; and (3) carry the force of a market imperative with a well-focused business plan and model that meet private venture capital funding criteria. The mix of NIT companies chosen will include neurotechnology innovations that are both Dare-To-Dream projects, as well as Better, Faster, Cheaper solutions to improve patient care.
How can our innovation be considered for NIT investment?
Wed love to hear from you. Contact us.
Does NIT have dedicated funds?
Yes, NIT has capital ready to fund your company--not just to get your company started, but to propel your company forward in each development and investment stage. Whether seeding your company, leading, or joining an investment syndicate, NIT offers dedicated strategic investment funds, as well as available capital resources from a variety of Partners including Ohio Third Frontier and The Ohio State University. NIT can invest alone or as part of a syndicate to ensure your company is adequately capitalized.
How much does NIT invest?
NIT has no set expectations for funding levels either in a given round, or over the life of a company. The amount of money a prospective NIT Company may receive from NIT is driven by the business needs and specifics of a companys operating plans and objectives. We may invest as little as $250k, or as much as $10M, depending upon the projects specific needs.
We only have an idea for an innovation. Is NIT appropriate for us?
Of course! Whether an idea on a napkin, or a more mature and established neurotechnology company that is further along in the development pathway, NIT is seeking the best innovations in neurotechnology, regardless of stage or origin. NIT could be the perfect ecosystem for taking your idea and translating it from concept-to-clinic.Wed love to hear from you.
We've already been working on our startup for a while. Is NIT appropriate for us?
Yes.Whether NIT is seeding a company, NIT is leading an investment, or NIT is joining an investment syndicate, provided your company can capitalize on the resources and ecosystem that we have to offer, we are interested. NIT has dedicated strategic investment funds, as well as available capital resources from a variety of Partners including Ohio Third Frontier and The Ohio State University for investment in your startup.
We've already taken some funding. Is NIT appropriate for us?
Sure. As mentioned above, whether NIT is seeding a company, NIT is leading an investment, or NIT is joining an investment syndicate, provided your company can capitalize on the resources and ecosystem that we have to offer, we are interested. We can probably help any startup that hasn't already raised an inordinate amount of capital, (e.g. already entering a third investment round from institutional investors). If you are unsure, contact us and we will let you know directly.
Will NIT syndicate alongside other investors and co-invest?
Yes, absolutely. Provided, however, that a company would significantly benefit from NITs resources and ecosystem for its development pathway.
We need investment capital, but already have all the resources we need. Is NIT appropriate for us?
NIT is not a venture capital firm. The capital NIT invests is only a small part of what NIT brings from its ecosystem for company development. If all that your company needs is investment capital, it is likely not a fit for NIT.
Will NIT invest in a company that is not in Ohio?
No. Your company might be able to leave a few employees at home, but the company needs to be headquartered in Ohio to attract NITs resources and investment capital. NIT and Ohio offer so much to companies, that unless your company is located within this ecosystem, it would likely not benefit from all the resources that NIT might bring.
Do we have to start a company in the US for you to invest in us?
No, not necessarily. NIT seeks projects from around the globe. If you've started your company outside the US (or outside of Ohio for that matter), and are interested in relocating to Ohio to tap into the NIT ecosystem, we would love to hear from you.
Do we have to work with your Partners?
No, not necessarily. NITs broad Partner ecosystem is there to help your company. We wouldnt expect your company to need all of themnor would we demand that you have to work with any specific Partner. That said, of course we would want to ensure that your company would sufficiently benefit from NITs resources and ecosystem for its development pathway to make the investment mutually beneficial.
What if we have a conflict with one of the NIT Partners?
NITs Partners are there for your company as needed. As a private entity, NIT is wholly separated. So, NIT can work independently with your company without any exposure to any particular Partner, as necessary.
Does our company need to use NITs facility?
Not necessarily. While NIT offers substantial space, facilities, and onsite resources, NIT Companies can locate anywhere within Ohio that is most conducive to their success.Some may reside initially within the NIT Center itself, some may be established elsewhere within Ohio, depending upon their specific needs and capabilities. Eventually your company will leave the facility in any respect, and matriculate outside and beyond NIT, within Ohio, as you reach your milestones and are funded as a fully independent company.
Will NIT sign an NDA?
No, NIT won't typically sign an NDA. Like a venture capital firm, we review far too many projects to sign NDAs, and believe that most of our exploratory conversations can be held without any exchange of sensitive proprietary information. And, as an experienced entrepreneur, you appreciate the relatively limited value of the idea itself, relative to the long path to execution that lies ahead for your company.
Is NIT hiring?
For a list of available opportunities at NIT or one of NITs Companies, click here.
See the original post:
- New Swiss initiative aims to widen access to groundbreaking neurotechnology - News-Medical.net - December 6th, 2019
- Neurotechnology Market Report 2019 | Industry Size, Share, Trend And Forecast Is A Professional And In-Depth Study By 2026 - Alpha News Report - December 6th, 2019
- Trying to read the 'mind of a group' shapes our decisions online - Futurity: Research News - December 6th, 2019
- Global Facial Recognition Market Top Key Players, Regions and Application Outlook Upto 2019 to 2028 - Industry Planning - December 6th, 2019
- Neurotechnology startup NextMind unveils world's first brain-sensing wearable that delivers real-time device control with just your thoughts -... - November 23rd, 2019
- NextMind Unveils World's First Brain-Sensing Wearable That Delivers Real-Time Device Control With Just Your Thoughts - Business Wire - November 23rd, 2019
- Neurotechnology and the Future of Hope - Robotics Tomorrow (press release) - August 25th, 2017
- Canaccord Genuity Keeps Rating And Raises Price Target On Stryker Corporation (SYK) - Modern Readers - August 25th, 2017
- Technology Key to Fighting Neurological Disease - R & D Magazine - August 25th, 2017
- Could this back-pain device end need for opioids? - The Columbus Dispatch - August 20th, 2017
- In the Future, Humans Will Use Brain to Brain Communication and Download Their Memories If Elon Musk Has His Way - Newsweek - August 14th, 2017
- Open-source Morpheo Platform to Use Artificial Intelligence to Help Diagnose Sleep Disorders - Sleep Review - August 8th, 2017
- Stryker Exceeded Analysts' Sales Estimates in 2Q17 - Market Realist - August 2nd, 2017
- Elon Musk talks of his life's 'highs' and 'lows' in a few painfully honest tweets - Mashable - July 31st, 2017
- Team Neurotechnology Innovations Translator - July 30th, 2017
- Stryker Corporation (NYSE:SYK) and Uroplasty (UPI) Financial Survey - Stock Observer - July 29th, 2017
- Tufts Hosts Engineering Conference - Tufts Now - July 28th, 2017
- Stryker reports 6.1% Q2 growth, installs 26 Mako systems: 7 things ... - Becker's Orthopedic & Spine - July 28th, 2017
- Arshya Vahabzadeh: Innovating at the Intersection of Brain, Behavior, and Technology - HuffPost - July 27th, 2017
- Capstone Asset Management Company Has Boosted By $555078 Its Raytheon Co (RTN) Holding, Stryker (SYK)'s ... - Herald KS - July 26th, 2017
- Trivascular Technologies (TRIV) & Stryker Corporation (SYK) Critical Review - Stock Observer - July 26th, 2017
- fMRI, EEG Tests May Detect Consciousness in Severe TBI Patients - PsychCentral.com - July 24th, 2017
- BRAIN center gathers to ponder future, direction - Arizona State University - July 20th, 2017
- Preserving the Right to Cognitive Liberty - Scientific American - July 19th, 2017
- Comparing Uroplasty (UPI) and Stryker Corporation (NYSE:SYK) - The Cerbat Gem - July 18th, 2017
- Insider Activity Stryker Corporation (NYSE:SYK) - Highlight Press - July 15th, 2017
- Neurotechnology: 5 braincomputer interface innovations - Red Bull - Red Bull - July 12th, 2017
- DARPA invests further in neurotechnology - SD Times - SDTimes.com - July 11th, 2017
- Infinitely Flexible 3D Printing with Ultrasonic Manipulation? - ENGINEERING.com - July 11th, 2017
- HIRREM Neurotechnology Better Than Placebo for Insomnia - Sleep Review - July 10th, 2017
- What is NIT? Neurotechnology Innovations Translator - July 5th, 2017
- Mind-blowing ultrasonic 'printer' uses lasers and high-frequency sound to assemble electronics - Digital Trends - July 1st, 2017
- Neurotechnology Explains Ultrasonic Manipulation in 3D Printing - 3DPrint.com - June 30th, 2017
- Neurotechnology Develops 3D Printing Method with Non-Contact Ultrasonic Manipulation Technology - 3DPrint.com - June 26th, 2017
- Neurotechnology makes a number of updates to the MegaMatcher product line - Biometric Update - June 23rd, 2017
- Neurotechnology adds face recognition, tracking to video surveillance systems; researchers win competition - Biometric Update - June 23rd, 2017
- SentiVeillance Server - Face Recognition and Analytics to Video Management Systems - Officer.com (press release) (registration) (blog) - June 22nd, 2017
- Brain data, neurotechnology and education | code acts in ... - June 21st, 2017
- Neurotechnology Announces SentiVeillance Server Facial Recognition Solution - findBIOMETRICS - June 21st, 2017
- New SentiVeillance Server from Neurotechnology Adds Face Recognition and Analytics to Video Management Systems - PR Newswire (press release) - June 19th, 2017
- Accuray (ARAY) versus Stryker Corporation (SYK) Head-To-Head Review - The Cerbat Gem - June 17th, 2017
- Helping or Hacking? Engineers, Ethicists Must Work Together on Brain-Computer Interface Technology - Government Technology - June 15th, 2017
- Neurotechnology Researchers Win Kaggle Competition with Deep Neural Network Solution for The Nature ... - PR Newswire (press release) - June 15th, 2017
- Neurotechnology Wins Fisheries-Focused Computer Vision ... - findBIOMETRICS - June 15th, 2017
- A Hardware Update for the Human Brain - HardOCP - June 15th, 2017
- Neurotechnology Releases MegaMatcher Accelerator Extreme, the Fastest Biometric Engine in the World - PR Newswire (press release) - June 14th, 2017
- Helping or hacking? Engineers and ethicists must work together on brain-computer interface technology - San Francisco Chronicle - June 14th, 2017
- Favorable Press Coverage Very Likely to Affect Stryker Corporation (SYK) Stock Price - Sports Perspectives - June 14th, 2017
- Neurotechnology Announces MegaMatcher Accelerator Extreme - findBIOMETRICS - June 12th, 2017
- Head to Head Analysis: Accuray (ARAY) and Stryker Corporation (SYK) - Sports Perspectives - June 12th, 2017
- Welch Capital Partners Increased By $3.59 Million Its Eqt (EQT) Position, Stryker (SYK) Sellers Decreased By 3.59 ... - UtahHerald.com - June 10th, 2017
- Comparing Accuray (ARAY) & Stryker (SYK) - The Cerbat Gem - June 9th, 2017
- Shoosmiths advises PD Neurotechnology on 1.34m (EUR) investment - Shoosmiths legal updates (press release) - June 7th, 2017
- Shoosmiths advises PD Neurotechnology on 1.34m investment - Scottish Legal News - June 7th, 2017
- Stryker (SYK) Earning Somewhat Favorable Media Coverage, Report Finds - Chaffey Breeze - June 5th, 2017
- Stryker (SYK) Receives Media Impact Score of 0.15 - Chaffey Breeze - June 3rd, 2017
- Scientists remotely move a mouse's whiskers with electrodes outside its brain - The Verge - June 1st, 2017
- The tiny cyborg dragonfly drones have taken flight - Mashable - June 1st, 2017
- Somewhat Positive Press Coverage Likely to Impact Stryker (SYK) Stock Price - The Cerbat Gem - June 1st, 2017
- Stryker (SYK) Getting Positive News Coverage, Study Shows - Chaffey Breeze - May 28th, 2017
- $20000 ONtrepreneurs Pitch Challenge Winner Announced - Canada NewsWire (press release) - May 23rd, 2017
- Rythm Accelerates Sleep Research and Neurotechnology Efforts With a Prestigious Scientific Advisory Board and ... - PR Newswire (press release) - May 13th, 2017
- Freedom of the mind under threat with new technology - BioEdge - May 8th, 2017
- Do We Have a Right to Mental Privacy and Cognitive Liberty? - Scientific American (blog) - May 4th, 2017
- Future tech could jeopardise 'freedom of mind': experts - Outlook India - Outlook India - May 2nd, 2017
- This Is Your Brain on Business - Fortune - May 2nd, 2017
- Future tech could jeopardise 'freedom of mind', say experts - Daily News & Analysis - April 30th, 2017
- Will your computer delete your thoughts? - TRUNEWS - April 28th, 2017
- Researchers advocate neurorights to protect brain data - The Stack - April 28th, 2017
- Download - Neurotechnology - April 27th, 2017
- Rise of Neurotechnology: Defend Against Brain Hackers Before It's Too Late - Sputnik International - April 27th, 2017
- A new category of human rights: neurorights - BMC Blogs Network (blog) - April 27th, 2017
- In a neuro-techno future, human rights laws will need to be revisited - Science Daily - April 27th, 2017
- New computers could delete thoughts without your knowledge ... - The Independent - April 27th, 2017
- Stryker Co. Announces Quarterly Dividend of $0.43 (SYK) - The Cerbat Gem - April 25th, 2017
- PTSD Symptoms May Be Eased by Non-Invasive Neurotechnology - Psychiatry Advisor - April 25th, 2017
- Academia, Industry Collaborate on Solutions to Neural Disease, Injury - Texas Medical Center (press release) - April 25th, 2017
- Reduction of Post -Traumatic Stress Symptoms Associated with Non-Invasive Neurotechnology - Newswise (press release) - April 19th, 2017
- Academia, industry collaborate on solutions to neural disease, injury - Medical Xpress - April 19th, 2017
- Analyst Activity Jefferies Group LLC Reiterates Hold on Stryker (NYSE:SYK) - Market Exclusive - April 15th, 2017